Cargando…

Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis

There is emerging evidence that the misfolding of superoxide dismutase 1 (SOD1) may represent a common pathogenic event in both familial and sporadic amyotrophic lateral sclerosis (ALS). To reduce the burden of misfolded SOD1 species in the nervous system, we have tested a novel therapeutic approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Priyanka, Kriz, Jasna, Gravel, Mathieu, Soucy, Geneviève, Bareil, Christine, Gravel, Claude, Julien, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944333/ https://www.ncbi.nlm.nih.gov/pubmed/24394188 http://dx.doi.org/10.1038/mt.2013.239

Ejemplares similares

Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Patel, Priyanka, et al.
Publicado: (2014)

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
por: Tokuda, Eiichi, et al.
Publicado: (2019)

The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
por: Martinelli, Ilaria, et al.
Publicado: (2022)

Protein kinetics of superoxide dismutase‐1 in familial and sporadic amyotrophic lateral sclerosis
por: Ly, Cindy V., et al.
Publicado: (2023)

Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase
por: Audet, Jean-Nicolas, et al.
Publicado: (2012)

Pathological Roles of Wild-Type Cu, Zn-Superoxide Dismutase in Amyotrophic Lateral Sclerosis
por: Furukawa, Yoshiaki
Publicado: (2012)

A seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis
por: Ogawa, Mariko, et al.
Publicado: (2014)

Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis
por: Forsberg, Karin, et al.
Publicado: (2011)

Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
por: Tokuda, Eiichi, et al.
Publicado: (2017)

The Role of Metal Binding in the Amyotrophic Lateral Sclerosis-Related Aggregation of Copper-Zinc Superoxide Dismutase
por: Sirangelo, Ivana, et al.
Publicado: (2017)

Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis
por: Ekhtiari Bidhendi, Elaheh, et al.
Publicado: (2018)

Anticipation and Phenotypic Heterogeneity in Korean Familial Amyotrophic Lateral Sclerosis with Superoxide Dismutase 1 Gene Mutation
por: Kim, Woojun, et al.
Publicado: (2007)

Glutathionylation potentiates benign superoxide dismutase 1 variants to the toxic forms associated with amyotrophic lateral sclerosis
por: McAlary, Luke, et al.
Publicado: (2013)

Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
por: Furukawa, Yoshiaki, et al.
Publicado: (2020)

Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
por: Rubino, Valentina, et al.
Publicado: (2023)

Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states
por: Prudencio, Mercedes, et al.
Publicado: (2011)

Superoxide Dismutases and Superoxide Reductases
por: Sheng, Yuewei, et al.
Publicado: (2014)

Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates
por: Matsumoto, Gen, et al.
Publicado: (2005)

Finding Inhibitors of Mutant Superoxide Dismutase-1 for Amyotrophic Lateral Sclerosis Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

A pathological link between dysregulated copper binding in Cu/Zn-superoxide dismutase and amyotrophic lateral sclerosis
por: Furukawa, Yoshiaki
Publicado: (2022)

Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients
por: Keskin, Isil, et al.
Publicado: (2016)

Transmission of ALS pathogenesis by the cerebrospinal fluid
por: Mishra, Pooja Shree, et al.
Publicado: (2020)

Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
por: Paré, Bastien, et al.
Publicado: (2018)

Redox environment is an intracellular factor to operate distinct pathways for aggregation of Cu,Zn-superoxide dismutase in amyotrophic lateral sclerosis
por: Furukawa, Yoshiaki
Publicado: (2013)

Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis
por: Anzai, Itsuki, et al.
Publicado: (2016)

Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis
por: Pereira, Gabriel Rodrigues Coutinho, et al.
Publicado: (2021)

Superoxide Dismutase 1 Folding Stability as a Target for Molecular Tweezers in SOD1‐Related Amyotrophic Lateral Sclerosis
por: Samanta, Nirnay, et al.
Publicado: (2022)

In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein
por: Pereira, Gabriel Rodrigues Coutinho, et al.
Publicado: (2023)

Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding
por: Grad, Leslie I, et al.
Publicado: (2014)

Modification of Superoxide Dismutase 1 (SOD1) Properties by a GFP Tag – Implications for Research into Amyotrophic Lateral Sclerosis (ALS)
por: Stevens, James C., et al.
Publicado: (2010)

Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis
por: Crown, Anthony M., et al.
Publicado: (2019)

Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations
por: Lange, Dale J., et al.
Publicado: (2017)

Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?
por: Lum, Jeremy S., et al.
Publicado: (2022)

Copper oxide nanoparticles trigger macrophage cell death with misfolding of Cu/Zn superoxide dismutase 1 (SOD1)
por: Gupta, Govind, et al.
Publicado: (2022)

Expression of a Cu,Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury
por: Goos, Miriam, et al.
Publicado: (2007)

An Allosteric Pathway in Copper, Zinc Superoxide Dismutase Unravels the Molecular Mechanism of the G93A Amyotrophic Lateral Sclerosis-Linked Mutation
por: Souza, Paulo C. T., et al.
Publicado: (2019)

Atypical Familial Amyotrophic Lateral Sclerosis Secondary to Superoxide Dismutase 1 Gene Mutation With Coexistent Axonal Polyneuropathy: A Challenging Diagnosis
por: Makkawi, Seraj, et al.
Publicado: (2022)

Superoxide Dismutases in Pancreatic Cancer
por: Wilkes, Justin G., et al.
Publicado: (2017)

Therapeutic potentials of superoxide dismutase
por: Younus, H.
Publicado: (2018)

Corneal endothelial integrity in aging mice lacking superoxide dismutase-1 and/or superoxide dismutase-3
por: Behndig, Anders
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_pm6p3r39bse8nr4l5kgqve2679